A Phase 3 interventional study of Continuous non-invasive blood pressure monitoring in Hip Fractures, Hypotension on Induction and Intraoperative Hypotension, sponsored by University Hospital Birmingham NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-18.
Sponsored by University Hospital Birmingham NHS Foundation Trust · Phase 3, Interventional, and Prevention
Background During anaesthesia for repair of a broken hip, many patients experience low blood pressure. There have been many studies showing that patients who experience low blood pressure during anaesthesia are at increased risk of sustaining kidney or heart damage, strokes, having a post-operative infection, or dying. During anaesthesia, in most cases blood pressure is monitored using a cuff which inflates on the arm (the 'normal' way blood pressure is measured in a GP practice or hospital ward). This gives a reading each time the cuff goes up and down, every 3-5 minutes typically. There is a less well used way to measure blood pressure, using an additional cuff on the finger which gives a constant, continuous measure of blood pressure. We think that using this monitor, rather than the 'standard' monitor, will mean that low blood pressure is recognised more quickly, therefore treated more quickly, and will lead to patients having less exposure to dangerously low blood pressures. If this is the case, we hope that it will reduce how often patients experience kidney or heart damage, have an infection after surgery, suffer a stroke, and reduce the risk of death.
Methodology To test this, we would need to run a large clinical trial comparing the continuous monitor to the standard monitor. This would be expensive and involve a great deal of work in a large number of hospitals, and so first we wish to determine whether the trial we would like to run is practical, and possible to deliver in the real world. To do this we plan to run the trial first on a small-scale feasibility (pilot) study, where we will recruit 30 patients, half of whom will have the standard monitor, and half of whom will have the continuous monitor. We will see what proportion of the patients who could enter the trial actually do so and complete it, and use it as an opportunity to iron out problems with the trial. If we find it is possible to run the trial on a small scale, we will apply for funding to run a full study. This will aim to answer the question of whether the continuous monitor improves the patient outcomes which were agreed during development with the patient public involvement group locally; rate of kidney damage, heart damage, stroke, post-operative infections, risk of death, and hospital length-of-stay.
Expected outcomes and implications. We anticipate we will find the trial to be feasible with amendments to the way it is run, and if this is the case, we will apply to run the full scale trial. If this shows that using the continuous monitor improves the patient outcomes above, then it would represent new, significant evidence that may lead to the NHS adopting it's use as 'standard care' during anaesthesia for repair of a broken hip, and would like lead to similar trials in other operations where patients may benefit in a similar way.
Exclusion Criteria:
CNAP monitoring applied, but screen and information not visible to treating anaesthetist
Device: Continuous non-invasive blood pressure monitoring
CNAP monitoring applied and available in full to the treating anaesthetist
Device: Continuous non-invasive blood pressure monitoring
Continuous non-invasive blood pressure monitoring using CNAP
Feasibility Outcome - Proportion of recruited patients in whom CNAP was successfully applied and full data collected.
Proportion of recruited patients in whom CNAP was successfully applied and full data collected.
Time frame: Through to study completion, an average of 5-6 weeks per patient.
Feasibility Outcome - Proportion of eligible patients successfully recruited
The proportion of all those patients who are eligible during the recruitment period who are successfully enrolled into the trial.
Time frame: Through to study completion, an average of 5-6 weeks per patient.
Feasibility Outcome - Proportion of enrolled patients in whom there is a full data set recorded.
Time frame: Through to study completion, an average of 5-6 weeks per patient.
Feasibility Outcome - Proportion of enrolled patients in which we are able to record full follow up data.
Time frame: Through to study completion, an average of 5-6 weeks per patient.
Intraoperative Outcomes - Nadir Blood Pressure
The lowest mean arterial pressure recorded during surgery using the CNAP monitor
Time frame: On the day of surgery only.
Intraoperative Outcomes - Total time spent with a mean arterial pressure <80mmHg
Time frame: On the day of surgery only.
Intraoperative Outcomes - Total time spent with a mean arterial pressure <65mmHg
Time frame: On the day of surgery only.
Intraoperative Outcomes - Total time spent with a mean arterial pressure <55mmHg
Time frame: On the day of surgery only.
Intraoperative Outcomes - Total volume of intravenous fluids given
Time frame: On the day of surgery only.
Intraoperative Outcomes - Total dose of vasopressors given
Broken down into totals of each separate vasopressor used.
Time frame: On the day of surgery only.
Post-operative Outcomes - Incidence of acute kidney injury in the 7 days post-operatively
Outcomes as per standardised definitions from the European Perioperative Clinical Outcome standards
Time frame: Assessed up to 7 days post-operatively.
Post-operative Outcomes - Incidence of myocardial injury in the first 3 days after surgery
Outcomes as per standardised definitions from the European Perioperative Clinical Outcome standards
Time frame: Assessed up to 3 days post-operatively.
Post-operative Outcomes - Incidence of stroke post-operatively
Outcomes as per standardised definitions from the European Perioperative Clinical Outcome standards
Time frame: Assessed up to 30 days post-operatively.
Post-operative Outcomes - Incidence of post-operative surgical site infection
As per CDC definitions
Time frame: Assessed up to 30 days post-operatively.
Post-operative Outcomes - Mortality
Time frame: Assessed at 30 days post-operatively.
Health Economic Outcome - Hospital Length of Stay
Time frame: Assessed at hospital discharge, an average of 10-14 days
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Birmingham NHS Foundation Trust